|
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX ... |
|
20.29% |
|
|
|
|
|
|
|
|
|
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
34.71% |
19.89% |
|---|
| ABBV |
AbbVie Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
27.65% |
25.61% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
45.18% |
73.01% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
33.04% |
35.06% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
0.52% |
|
|
|
|
|
N/A |
0.00% |
35.09% |
32.21% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
82.04% |
56.49% |
|---|
| AMGN |
Amgen Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
34.50% |
47.20% |
|---|
| BIIB |
Biogen Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
37.26% |
39.84% |
|---|
| NTRA |
Natera, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
53.42% |
16.92% |
|---|
| INCY |
Incyte Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
42.37% |
45.07% |
|---|
| INSM |
Insmed Incorporated |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
46.27% |
69.48% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
41.52% |
10.53% |
|---|
| MRNA |
Moderna, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
67.24% |
33.78% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
40.67% |
53.12% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
0.48% |
|
|
|
|
|
N/A |
0.00% |
46.55% |
11.01% |
|---|
| PCVX |
Vaxcyte, Inc. |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
62.20% |
45.63% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
0.46% |
|
|
|
|
|
N/A |
0.00% |
29.42% |
23.44% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
56.48% |
7.87% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
55.57% |
32.86% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
37.56% |
28.21% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
61.15% |
29.28% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
61.47% |
8.15% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
57.02% |
22.76% |
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
0.33% |
|
|
|
|
|
N/A |
0.00% |
32.36% |
51.52% |
|---|
| BPMC |
Blueprint Medicines Corporation |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
66.68% |
-1.50% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
43.44% |
36.38% |
|---|
| CYTK |
Cytokinetics, Incorporated |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
54.27% |
22.39% |
|---|
| RVMD |
Revolution Medicines, Inc. |
0 |
0.30% |
|
|
|
|
|
N/A |
0.00% |
66.81% |
45.98% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
0.28% |
|
|
|
|
|
N/A |
0.00% |
35.76% |
25.36% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
0 |
0.28% |
|
|
|
|
|
N/A |
0.00% |
60.00% |
3.74% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
54.77% |
39.68% |
|---|
| ALKS |
Alkermes plc |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
55.46% |
60.80% |
|---|
| SMMT |
Summit Therapeutics Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
47.40% |
15.30% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
46.12% |
38.93% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
67.15% |
53.95% |
|---|
| BHVN |
Biohaven Pharmaceutical Holding Company ... |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
62.50% |
58.75% |
|---|
| NUVL |
Nuvalent, Inc. |
0 |
0.19% |
|
|
|
|
|
N/A |
0.00% |
47.10% |
50.09% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
66.71% |
37.00% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
27.90% |
4.64% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
71.90% |
96.83% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
97.46% |
52.30% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
46.99% |
18.43% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
70.01% |
15.27% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
764.53% |
60.34% |
|---|
| GERN |
Geron Corporation |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
92.88% |
14.58% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
230.48% |
61.07% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
48.11% |
30.11% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
68.70% |
21.79% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
65.71% |
40.77% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
62.23% |
31.55% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
48.14% |
22.97% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
62.30% |
18.58% |
|---|
| VRDN |
Viridian Therapeutics, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
48.83% |
22.98% |
|---|
| DVAX |
Dynavax Technologies Corporation |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
247.79% |
38.66% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
51.71% |
46.71% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
84.48% |
58.18% |
|---|
| TVTX |
Travere Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
77.53% |
-0.77% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
80.40% |
47.61% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
142.62% |
25.74% |
|---|
| NVAX |
Novavax, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
58.17% |
1.51% |
|---|
| SLNO |
Soleno Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
69.57% |
13.25% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
63.92% |
40.25% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
64.25% |
46.03% |
|---|
| IMVT |
Immunovant, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
77.80% |
43.14% |
|---|
| JANX |
Janux Therapeutics, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
81.13% |
18.74% |
|---|
| ARDX |
Ardelyx, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
88.22% |
64.24% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
54.39% |
20.05% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
66.75% |
110.05% |
|---|
| PRAX |
Praxis Precision Medicines, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
167.62% |
41.00% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
56.04% |
28.59% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
52.38% |
63.01% |
|---|
| CDNA |
CareDx, Inc |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
110.71% |
21.02% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
42.34% |
25.01% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
58.27% |
74.40% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
102.73% |
12.07% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
67.83% |
40.49% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
67.60% |
14.75% |
|---|
| SNDX |
Syndax Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
77.62% |
59.19% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
60.35% |
59.06% |
|---|
| NRIX |
Nurix Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
80.19% |
27.11% |
|---|
| MNKD |
MannKind Corporation |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
103.04% |
78.92% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
73.43% |
29.70% |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
62.90% |
59.51% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
49.91% |
39.41% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
217.96% |
72.73% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
50.70% |
25.81% |
|---|
| SYRE |
Spyre Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
139.55% |
34.90% |
|---|
| CAPR |
Capricor Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
128.94% |
51.37% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
76.09% |
52.04% |
|---|
| IBRX |
ImmunityBio, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
162.94% |
53.53% |
|---|
| SPRY |
ARS Pharmaceuticals, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
83.18% |
11.45% |
|---|
| CDMO |
AVID BIOSERVICES INC |
|
0.05% |
|
|
|
|
|
|
|
|
|
|---|
| HUMA |
Humacyte, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
87.95% |
20.50% |
|---|
| KURA |
Kura Oncology, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
107.72% |
38.44% |
|---|
| XNCR |
Xencor, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
81.40% |
30.75% |
|---|
| COGT |
Cogent Biosciences, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
389.75% |
60.67% |
|---|
| ALT |
Altimmune, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
254.08% |
111.90% |
|---|
| EBS |
Emergent BioSolutions Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
245.53% |
12.99% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
286.49% |
76.20% |
|---|